CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 49,468	$ 73,424
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Provision for credit losses	3,793	14,996
Other-than-temporary impairment on investments	214	74
Impairment charges		2,280
Unrealized gain on trading securities	(774)	(1,108)
Equity in earnings of unconsolidated entities	(2,528)	(2,882)
Gain on sale and deconsolidation of subsidiaries		(54,542)
Loss from discontinued operations	2	38
Net cash provided by (used in) operating activities	18,736	(19,218)
CASH FLOWS FROM INVESTING ACTIVITIES:
Net cash provided by investing activities	206,967	94,571
CASH FLOWS FROM FINANCING ACTIVITIES:
Repurchase of common stock		(1,385)
Net cash used in financing activities	(217,792)	(67,853)
CASH FLOWS FROM DISCONTINUED OPERATIONS:
Operating activities	(371)	(910)
Net cash used in discontinued operations	(371)	(910)
Increase in cash	7,540	6,590
Cash, beginning of year	11,899	12,803
Cash, end of period	19,439	19,393
Consolidated Entity Excluding RSO [Member]
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	49,468	73,424
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization	1,462	1,788
Provision for credit losses	3,793	14,996
Other-than-temporary impairment on investments	214	74
Impairment charges	0	2,280
Unrealized gain on trading securities	(774)	(1,108)
Equity in earnings of unconsolidated entities	(2,528)	(2,882)
Distributions from unconsolidated entities	3,099	2,300
Gain on sale of investment securities, net	(4,551)	(914)
Gain on sale of assets	(1,632)	(84)
Gain on sale and deconsolidation of subsidiaries	0	(54,542)
Deferred income tax (benefit) provision	(254)	13,239
Equity-based compensation issued	942	788
Trading securities purchases and sales, net	6,445	(1,048)
Loss from discontinued operations	2	38
Changes in operating assets and liabilities	1,465	(1,479)
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures	(1,035)	(116)
Payments received on real estate loans and real estate	2,049	176
Investments in real estate and unconsolidated real estate entities	(2,058)	(1,481)
Principal payments received on leases and loans	8	12
Proceeds from sale of Apidos, net of transaction costs and cash divested on deconsolidation	0	17,860
Purchase of loans and investments	(2,024)	(1,274)
Proceeds from sale of loans and investments	0	55
CASH FLOWS FROM FINANCING ACTIVITIES:
Increase in borrowings	2,000	0
Principal payments on borrowings	(2,354)	(5,593)
Dividends paid	(1,194)	(1,741)
Proceeds from issuance of common stock	1,253	2,131
Repurchase of common stock	(1,601)	(1,385)
Other	81	(56)
CASH FLOWS FROM DISCONTINUED OPERATIONS:
Cash, beginning of year	11,899
Cash, end of period	19,439
VIE - RSO [Member]
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Changes in cash attributable to operations of consolidated VIE- RSO	(38,415)	(66,088)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of loans and investments	(675,650)	(549,826)
Principal payments and proceeds from sales received by consolidated VIE - RSO	842,252	540,117
Increase in restricted cash of consolidated VIE - RSO	30,079	85,413
Other investing activity of consolidated VIE - RSO	13,346	3,635
CASH FLOWS FROM FINANCING ACTIVITIES:
Dividends paid		(52,688)
Other	(13,081)	(2,839)
Net repayments of debt by consolidated VIE - RSO	(320,834)	(128,019)
Dividends paid on common stock of consolidated VIE - RSO	(66,341)	(52,688)
Net proceeds from issuance of common stock by consolidated VIE - RSO	$ 184,279	$ 122,337